التفاصيل البيبلوغرافية
| العنوان: |
Incidence, clinical relevance and therapeutic options for outflow graft stenosis in patients with left ventricular assist devices. |
| المؤلفون: |
Dimitrov, Kamen, Kaider, Alexandra, Angleitner, Philipp, Schlöglhofer, Thomas, Gross, Christoph, Beitzke, Dietrich, Granegger, Marcus, Riebandt, Julia, Wiedemann, Dominik, Sandner, Sigrid, Schaefer, Anne-Kristin, Schima, Heinrich, Laufer, Günther, Zimpfer, Daniel |
| المصدر: |
European Journal of Cardio-Thoracic Surgery; Mar2022, Vol. 61 Issue 3, p716-724, 9p |
| مصطلحات موضوعية: |
HEART assist devices, CARDIOGENIC shock, ARTIFICIAL blood circulation, STENOSIS, PROTECTIVE coverings, PROTECTIVE coatings |
| مستخلص: |
Open in new tab Download slide Open in new tab Download slide OBJECTIVES We reviewed our institutional experience with outflow graft stenosis (OGS) in 3 contemporary left ventricular assist devices (LVAD). METHODS Data from 347 consecutive adult recipients of LVAD [Medtronic HVAD (n = 184, 53.0%), Abbott HeartMate II (n = 62, 17.9%) and Abbott HeartMate 3 (n = 101, 29.1%)] implanted between March 2006 and October 2019 were analysed retrospectively. Primary study end points were the incidence of OGS necessitating treatment and survival on LVAD support. RESULTS During the study period, 17 patients (4.9%) developed OGS requiring treatment with a probability of 0.6% at 1 year, 1.9% at 2 years, 3.8% at 3 years, 4.7% at 4 years and 5.9% at 5 years of LVAD support. Notably, in 13.8% of patients, a compression-related narrowing of the outflow graft with a probability of 1.5% at 6 months, 1.8% 1 year, 6.0% at 2 years, 12.3% at 3 years, 15.4% at 4 years and 16.6% at 5 years of LVAD support with no difference between devices (P = 0.26) was observed. There was a trend towards increased risk of mortality with OGS (hazard ratio 2.21, 95% confidence interval 0.87–5.51; P = 0.09). OGS preferentially occurred in segments of the outflow graft covered by a protective coating. CONCLUSIONS OGS is a rare but potentially lethal complication during LVAD support. Modifications of pump design and implant techniques may be needed because OGS preferentially occurs within covered portions of the outflow graft. Systematic screening may be warranted. [ABSTRACT FROM AUTHOR] |
|
Copyright of European Journal of Cardio-Thoracic Surgery is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder